L-Methionine Encyclopedia — Scientific Background

What Is L-Methionine?

L-Methionine (CAS 63-68-3), also known as (2S)-2-amino-4-(methylsulfanyl)butanoic acid or L-2-amino-4-(methylthio)butanoic acid, is an essential sulfur-containing amino acid with the molecular formula C₅H₁₁NO₂S and a molecular weight of 149.21 g/mol. It is a white crystalline powder with a characteristic odor and slight bitter taste, and is soluble in water (30 g/L at 20°C). L-Methionine is one of the 20 standard proteinogenic amino acids and is classified as an essential amino acid because the human body cannot synthesize it, requiring dietary intake through high-protein foods including meat, milk, eggs, and fish.

Physiological Functions of L-Methionine

L-Methionine is an essential sulfur-containing amino acid with several critical physiological roles:

• Protein Synthesis — As a proteinogenic amino acid, L-methionine is a fundamental building block for protein synthesis and serves as the initiating amino acid in translation.

• Methyl Donor (SAMe Precursor) — L-Methionine is converted to S-adenosyl-L-methionine (SAMe), the primary methyl donor for numerous biological methylation reactions, including DNA methylation, neurotransmitter synthesis, and phospholipid metabolism.

• Glutathione Precursor — L-Methionine is a precursor to L-cysteine, which is a rate-limiting substrate for glutathione synthesis, the body‘s master antioxidant.

• Sulfur Metabolism — As a sulfur-containing amino acid, L-methionine is the primary source of sulfur in the human body, contributing to the synthesis of cysteine, taurine, and other sulfur-containing compounds.

• Heavy Metal Chelation — L-Methionine is a transporter of the antioxidant mineral selenium and assists with the transport of selenium and zinc.

Metabolic Pathways and Mechanisms of Action

SAMe and Methylation Cycle

L-Methionine is converted to SAMe by methionine adenosyltransferase in an ATP-dependent reaction. SAMe serves as the primary methyl donor for numerous transmethylation reactions catalyzed by methyltransferases, including DNA methyltransferases, histamine N-methyltransferase, and catechol-O-methyltransferase. After donating its methyl group, SAMe is converted to S-adenosylhomocysteine (SAH), which is then hydrolyzed to homocysteine. Homocysteine can be remethylated back to methionine via the folate/vitamin B12-dependent methionine synthase pathway or the betaine-dependent BHMT pathway, completing the methionine cycle.

Transsulfuration Pathway and Glutathione Synthesis

Homocysteine can alternatively enter the transsulfuration pathway, where it is converted to cystathionine by cystathionine β-synthase (CBS) and then to cysteine by cystathionine γ-lyase (CSE). Cysteine is the rate-limiting substrate for glutathione (GSH) synthesis, making L-methionine an indirect precursor to the body’s master antioxidant. This pathway also produces taurine, a sulfur-containing amino acid with cardiovascular and neurological benefits.

Liver Regeneration and Detoxification

Cells in the liver and kidneys especially need L-methionine for regeneration. It helps to break down fats and assists with choline production, supporting hepatic lipid metabolism and preventing fatty liver. L-Methionine is also involved in the conjugation and detoxification of xenobiotics and heavy metals.

Clinical Evidence

Immune Support in HIV-Infected Patients

A double-blind, placebo-controlled study was conducted in 253 HIV-infected patients from four different trial centres. Patients were randomly divided into two groups, active and placebo, and regularly assessed by clinical and safety parameters. After six months from commencement, clinically and statistically significant differences were observed. The females of the active treatment group presented with a decreased level of decline in their CD4 counts (p = 0.0027), as did the patients of Centre 1 (p = 0.0377). All patients were placed onto active treatment after 12 months and were followed up for 48 months after the trial started. The same tendencies could be observed in the group as a whole, with no serious side effects directly associated with treatment. The study confirmed the supportive role of L-methionine in immune-compromised or deficient patients.

Liver Health

L-Methionine is used for liver support and regeneration, particularly in conditions involving hepatic lipid accumulation and oxidative stress. It assists with choline production and the breakdown of fats, supporting normal liver function.

Heavy Metal and Antioxidant Support

L-Methionine is a transporter of the antioxidant mineral selenium and assists with the transport of selenium and zinc. It contributes to the synthesis of glutathione, which protects cells from oxidative damage and supports detoxification pathways.

The Bioavailability Challenge

Despite its essential physiological functions, native L-methionine presents significant formulation challenges. As a large neutral amino acid, it competes with other LNAAs for transport across the intestinal epithelium and the blood-brain barrier via the L-type amino acid transporter (LAT1). This competition limits the fraction of orally administered L-methionine that reaches systemic circulation and target tissues.

liposomal encapsulation addresses these limitations through a phospholipid bilayer that protects L-methionine during digestive transit and provides an alternative absorption pathway that bypasses the competitive LNAA transporter. Lipid-based carriers and liposomal delivery systems improve the permeability and transport efficiency of L-methionine, enhancing its availability to target tissues including the liver, brain, and kidneys.

Liposomal L-methionine

Liposomal encapsulation of L-methionine provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the L-methionine molecule, forming a protective shell that enhances stability, absorption, and cellular uptake. This delivery system:

• Improves absorption by enhancing permeability across biological membranes

• Bypasses the competitive LNAA transport pathway

• Provides sustained release for balanced methylation support

• Enhances water dispersibility for use in aqueous formulations

Safety and Regulatory

L-Methionine is generally well tolerated at commonly used doses. However, several important precautions must be observed:

Safety Considerations:

• L-Methionine may increase the blood levels of homocysteine in some individuals.

• Not to be taken by pregnant or breastfeeding women without medical supervision.

• During methionine supplementation, intake of taurine, cysteine, and other sulfur-containing amino acids, as well as P5P and folate/folinic acid, should also be included for optimal metabolic balance.

Toxicity Data:

• Acute toxicity LD50 in rats: 4,300 mg/kg body weight (intraperitoneal); in chickens: 3,700 mg/kg (intraperitoneal).

• L-Methionine is regulated as a human nutrient/dietary supplement and is allowed as a special nutritional and dietary food additive for human consumption under 21 CFR 172.320.

• L-Methionine is the only form of methionine permitted for use in infant food per FDA regulations.

L-Methionine is widely commercialized as a dietary supplement ingredient and food additive. It is monographed in the USP, European Pharmacopoeia, British Pharmacopoeia, and Japanese Pharmacopoeia (JP). Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

89$/KG